Scientific Advisory Board

Scientific Advisory Board

The quality of research at the Max Planck Institute for Molecular Genetics is regularly evaluated by a Scientific Advisory Board. The members of this board are internationally renowned scientists appointed by the president of the Max Planck Society. They generally do not belong to the Max Planck Society.

Members of the Scientific Advisory Board (appointment period 2014 - 2016)

Prof. Dr. Stephan Beck
Cancer Institute
University College, London, UK

Prof. Dr. Margaret Buckingham
Unité de Génétique Moléculaire du Développement
Institut Pasteur, CNRS URA 2578, Paris, Frankreich

Prof. Dr. Niklas Dahl
Department of Genetics and Pathology
Rudbeck Laboratory
Uppsala University, Children´s Hospital, Uppsala, Sweden

Prof. Dr. Kristian Helin
BRIC Biotech Research and Innovation Center
University of Kopenhagen, Denmark

Prof. Dr. Stanislas Lyonnet
Hôpital Necker-Enfants Malades
INSERM U781
Université Paris Descartes, Paris, France

Prof. Dr. Hanah Margalit
Department of Microbiology and Molecular Genetics
The Hebrew University of Jerusalem, Israel

Prof. Dr. Joe Nadeau, PhD,
Pacific Northwest Diabetes Research Institute
Seattle, USA

Prof. Dr. Chris Ponting
MRC Functional Genomics Unit
University of Oxford, UK

Prof. Dr. Ellen Solomon
Dept. of Medical and Molecular Genetics
King's College London, UK

Prof. Dr. Patrick Tam
Embryology Unit, Children's Medical Research Institute
University of Sydney, Wentworthville, Australia

Prof. Dr. Marc Vidal
Center for Cancer Systems Biology
Dana-Farber Cancer Institute, Boston, USA

Prof. Dr. Magdalena Zernicka-Goetz
Gurdon Institute, University of Cambridge
Wellcome Trust/Cancer Research Institute, Cambridge, UK

 
loading content